Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Aerosolized Liposomal Amikacin and Laryngeal Injury.

Literature DB >> 34488977

Aerosolized Liposomal Amikacin and Laryngeal Injury.

Colin Swenson¹, Juzar Ali².

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2021 PMID： 34488977 PMCID： PMC8579316 DOI： 10.1016/j.chest.2021.05.050

Source DB: PubMed Journal: Chest ISSN： 0012-3692 Impact factor: 10.262

Keyword Cloud
References

× No keyword cloud information.

5 in total

1. Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT). A Prospective, Open-Label, Randomized Study.

Authors: David E Griffith; Gina Eagle; Rachel Thomson; Timothy R Aksamit; Naoki Hasegawa; Kozo Morimoto; Doreen J Addrizzo-Harris; Anne E O'Donnell; Theodore K Marras; Patrick A Flume; Michael R Loebinger; Lucy Morgan; Luigi R Codecasa; Adam T Hill; Stephen J Ruoss; Jae-Joon Yim; Felix C Ringshausen; Stephen K Field; Julie V Philley; Richard J Wallace; Jakko van Ingen; Chris Coulter; James Nezamis; Kevin L Winthrop
Journal: Am J Respir Crit Care Med Date: 2018-12-15 Impact factor: 21.405

Review 2. Laryngeal involvement in rheumatoid arthritis.

Authors: P V Voulgari; D Papazisi; M Bai; P Zagorianakou; D Assimakopoulos; A A Drosos
Journal: Rheumatol Int Date: 2005-03-11 Impact factor: 2.631

3. Laryngeal Injury Due to Amikacin Inhalation for Refractory Mycobacterium avium Complex Infection.

Authors: Lucas G Axiotakis; Necati Enver; Claire L Keating; Michael J Pitman
Journal: Chest Date: 2021-04-06 Impact factor: 9.410

4. Clinical Management of Respiratory Adverse Events Associated With Amikacin Liposome Inhalation Suspension: Results From a Patient Survey.

Authors: Colin Swenson; Nicole C Lapinel; Juzar Ali
Journal: Open Forum Infect Dis Date: 2020-03-02 Impact factor: 3.835

5. Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline.

Authors: Charles L Daley; Jonathan M Iaccarino; Christoph Lange; Emmanuelle Cambau; Richard J Wallace; Claire Andrejak; Erik C Böttger; Jan Brozek; David E Griffith; Lorenzo Guglielmetti; Gwen A Huitt; Shandra L Knight; Philip Leitman; Theodore K Marras; Kenneth N Olivier; Miguel Santin; Jason E Stout; Enrico Tortoli; Jakko van Ingen; Dirk Wagner; Kevin L Winthrop
Journal: Clin Infect Dis Date: 2020-08-14 Impact factor: 9.079

5 in total